关于知识产权 知识产权培训 树立尊重知识产权的风尚 知识产权外联 部门知识产权 知识产权和热点议题 特定领域知识产权 专利和技术信息 商标信息 工业品外观设计信息 地理标志信息 植物品种信息(UPOV) 知识产权法律、条约和判决 知识产权资源 知识产权报告 专利保护 商标保护 工业品外观设计保护 地理标志保护 植物品种保护(UPOV) 知识产权争议解决 知识产权局业务解决方案 知识产权服务缴费 谈判与决策 发展合作 创新支持 公私伙伴关系 人工智能工具和服务 组织简介 与产权组织合作 问责制 专利 商标 工业品外观设计 地理标志 版权 商业秘密 WIPO学院 讲习班和研讨会 知识产权执法 WIPO ALERT 宣传 世界知识产权日 WIPO杂志 案例研究和成功故事 知识产权新闻 产权组织奖 企业 高校 土著人民 司法机构 遗传资源、传统知识和传统文化表现形式 经济学 金融 无形资产 性别平等 全球卫生 气候变化 竞争政策 可持续发展目标 前沿技术 移动应用 体育 旅游 PATENTSCOPE 专利分析 国际专利分类 ARDI - 研究促进创新 ASPI - 专业化专利信息 全球品牌数据库 马德里监视器 Article 6ter Express数据库 尼斯分类 维也纳分类 全球外观设计数据库 国际外观设计公报 Hague Express数据库 洛迦诺分类 Lisbon Express数据库 全球品牌数据库地理标志信息 PLUTO植物品种数据库 GENIE数据库 产权组织管理的条约 WIPO Lex - 知识产权法律、条约和判决 产权组织标准 知识产权统计 WIPO Pearl(术语) 产权组织出版物 国家知识产权概况 产权组织知识中心 产权组织技术趋势 全球创新指数 世界知识产权报告 PCT - 国际专利体系 ePCT 布达佩斯 - 国际微生物保藏体系 马德里 - 国际商标体系 eMadrid 第六条之三(徽章、旗帜、国徽) 海牙 - 国际外观设计体系 eHague 里斯本 - 国际地理标志体系 eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange 调解 仲裁 专家裁决 域名争议 检索和审查集中式接入(CASE) 数字查询服务(DAS) WIPO Pay 产权组织往来账户 产权组织各大会 常设委员会 会议日历 WIPO Webcast 产权组织正式文件 发展议程 技术援助 知识产权培训机构 COVID-19支持 国家知识产权战略 政策和立法咨询 合作枢纽 技术与创新支持中心(TISC) 技术转移 发明人援助计划(IAP) WIPO GREEN 产权组织的PAT-INFORMED 无障碍图书联合会 产权组织服务创作者 WIPO Translate 语音转文字 分类助手 成员国 观察员 总干事 部门活动 驻外办事处 职位空缺 采购 成果和预算 财务报告 监督
Arabic English Spanish French Russian Chinese
法律 条约 判决 按管辖区浏览

Law of the Republic of Tajikistan No. 861 of July 3, 2012, on the Introduction of Amendments and Additions to the Law of the Republic of Tajikistan 'On Pharmaceuticals and Pharmaceutical Activities', 塔吉克斯坦

返回
WIPO Lex中的最新版本
详情 详情 版本年份 2012 日期 议定: 2012年7月3日 文本类型 其他文本 主题 未披露的信息(商业秘密) The notification by Tajikistan to the WTO under Article 63.2 of TRIPS states:
'[This Amendment Act] reflects provisions of TRIPS Article 39 in respect of pharmaceuticals.'

可用资料

主要文本 相关文本
主要文本 主要文本 英语 Law of the Republic of Tajikistan No. 861 of July 3, 2012, on the Introduction of Amendments and Additions to the Law of the Republic of Tajikistan 'On Pharmaceuticals and Pharmaceutical Activities'        
 
下载PDF open_in_new
 Law of the Republic of Tajikistan No. 861 of July 3, 2012, on the Introduction of Amendments and Additions to the Law of the Republic of Tajikistan "On Pharmaceuticals and Pharmaceutical Activities"

LAW OF THE REPUBLIC OF TAJIKISTAN

ON INTRODUCTION OF AMENDMENTS AND ADDITIONS TO THE LAW OF THE REPUBLIC OF TAJIKISTAN “ON PHARMACEUTICALS AND

PHARMACEUTICAL ACTIVITIES”

Article 1. To introduce following amendment and additions to the Law of the Republic of Tajikistan as of August 6, 2001 “On pharmaceuticals and pharmaceutical activity” (Bulletin of the Majlisi Oli of the Republic of Tajikistan, No. 7. Page 499 2001; №12 page 700 2003; №5 page 375 2007; No. 6, page 467 2008):

1. To add paragraphs 31, 32, 33 and 34 to the Article 3 that read as follows:

"Pharmaceutical substances are pharmaceuticals in the form of active biotechnological, biological, mineral or chemical substances that possess pharmacological features used for the production, manufacture of pharmaceuticals and determining their therapeutic efficacy. Circulation of pharmaceuticals - development, preclinical and clinical researches appraisal, state registration, standardization and quality control, efficiency, safety, production, manufacture, storage, transportation, import and export to/from the territory of the Republic of Tajikistan and its dispensing, sale, use, application, advertisement and destruction of pharmaceuticals.

Invented name of the pharmaceutical is the name of a drug determined by its manufacturer.

Certificate of pharmaceutical product and medical supplies is a document that sets the legal status of a particular product as medical or pharmaceutical product and allows its use in healthcare.

2. Article 8: - To add the words “ pharmaceuticals and” in the title and after the “control” in

the first part; - To add second, third and fourth parts that read as follows:

“State Control of pharmaceutical activity and pharmaceuticals in the Republic of Tajikistan is arranged over the production of drugs within the country and their import to the territory of the Republic of Tajikistan.

State control of circulation of pharmaceuticals includes the control over the clinical trials of drugs, quality, efficiency, production, manufacturing, storage, transportation, import/export to/from the territory of the Republic of Tajikistan, and dispensing, sale, use, application, advertisement and destruction of pharmaceuticals.

State control over the circulation of the pharmaceuticals is arranged via:

- Verification of compliance with the rules of laboratory and clinical practices in during the preclinical and clinical studies of drugs used in health and veterinary; rules for the organization of production, quality control of pharmaceuticals, wholesale trade of drugs, manufacturing and dispensing of drugs, storage and disposal of pharmaceuticals;

- inspections for compliance with the conditions and requirements of issued licenses;

- verifications of quality of drugs; - studying and monitoring the effectiveness and safety of pharmaceuticals; - obtaining information on prices and margins (markups) from state agencies

and entities handling the circulation of pharmaceuticals; - second and third parts shall be considered as part 5 and 6 respectively.

3. To replace the word “institutions” with “legal persons and individual entrepreneurs” in the second part of the article 10.

4. To complement Part 2 of the Article 12 with the wording “as well as pharmaceutical substances” after the word "means.”

5. To replace the words “in pharmacies” with the "legal persons and individual entrepreneurs that have a license for pharmaceutical activity” in the fourth part of the article 14.

6. To add the wording “legal persons and individual entrepreneurs” after the word “institutions” in the first part of the article 16.

7. Article 20:

- to replace the word “pharmacies” with the wording “pharmacies, including individual entrepreneurs” in the third part;

- to add fourth, fifth, sixth and seventh paragraphs that read as follows:

"State registration shall be prohibited, if:

- Two or more drugs having different compositions are produced under the same brand name;

- the same drug is manufactured by the same manufacturer under the different trade names and submitted for state registration as two or more drugs.

Registration certificate is given to the registered drug for the period of five years with indication of dosage forms and quantization (dosage).

Subsequent confirmation of the registration certificates is arranged prior to the expiration of the registration certificate by the Authorized agency of the Government of the Republic of Tajikistan responsible for the state control of pharmaceutical activities on the basis of the application of the holder of registration certificate.

Information on pharmaceuticals and medical products that have passed state registration at the demand of the natural or legal persons can be confidential if:

- a drug or its composition is not known to persons engaged in the similar activities and manufacturer has to keep it secret;

- secrecy is conditioned by its commercial value; - Fourth and fifth parts shall be considered as parts eight and nine.

8. Article 30: - to add the words “and individual entrepreneurs” after the words "legal persons"

in the first part; - to add part 3 that reads as follows: "Individuals with secondary or higher professional pharmaceutical education and who have a professional certificate in pharmaceutical activities may engage in pharmaceutical activities (intake, storage, retail sale of pharmaceuticals and medical goods) as individual entrepreneurs after the obtaining of a certificate of state registration as an individual entrepreneur";

- Third, fourth and fifth parts shall be considered as parts four, five and six respectively.

Article 2. Present Law shall come into force after its official publication.

President Emomali Rahmon Republic of Tajikistan

Dushanbe July 3 2012 # 861


立法 修正 (1 文本) 修正 (1 文本) 世贸组织文件号
IP/N/1/TJK/4 & IP/N/1/TJK/O/1
无可用数据。

WIPO Lex编号 TJ059